Epigenetic extracellular vesicle-based biomarkers for urological malignancies: is the hope worth the hype?

Diana Montezuma1,2, Ana Teixeira-Marques1,3, Carmen Jerónimo1,4

  • 1Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto, 4200-072, Portugal.

Epigenomics
|October 7, 2021
PubMed
Abstract

No abstract available in PubMed .